Literature DB >> 19675814

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia.

Gagan Gautam1, Nitin Arora.   

Abstract

Entities:  

Year:  2007        PMID： 19675814      PMCID： PMC2721546     

Source DB:  PubMed          Journal:  Indian J Urol        ISSN： 0970-1591


× No keyword cloud information.
  3 in total

Review 1.  Transurethral ethanol ablation of prostate.

Authors:  Noor N P Buchholz; Henry O Andrews; Mark K Plante
Journal:  J Endourol       Date:  2004-08       Impact factor: 2.942

Review 2.  Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia.

Authors:  R C Harkaway; M M Issa
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-06-06       Impact factor: 5.554

3.  Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.

Authors:  P Grise; M Plante; J Palmer; J Martinez-Sagarra; C Hernandez; M Schettini; M Gonzalez-Martin; J Castiñeiras; P Ballanger; P Teillac; F Rolo; V Baena; J Erdmann; V Mirone
Journal:  Eur Urol       Date:  2004-10       Impact factor: 20.096
  3 in total
  1 in total

1.  Benign prostatic hyperplasia: An overview of existing treatment.

Authors:  Neelima Dhingra; Deepak Bhagwat
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.